S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Coherus Biosciences Price Target & Analyst Ratings (NASDAQ:CHRS)

$19.15
-0.12 (-0.62 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$18.84
Now: $19.15
$19.72
50-Day Range
$18.29
MA: $20.54
$23.75
52-Week Range
$8.32
Now: $19.15
$23.91
Volume650,974 shs
Average Volume973,634 shs
Market Capitalization$1.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.94

Analyst Ratings

Coherus Biosciences (NASDAQ:CHRS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Coherus Biosciences in the last 12 months. Their average twelve-month price target is $32.57, suggesting that the stock has a possible upside of 70.09%. The high price target for CHRS is $45.00 and the low price target for CHRS is $25.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.57$32.57$30.17$30.20
Price Target Upside: 70.09% upside73.81% upside48.68% upside104.61% upside

Coherus Biosciences (NASDAQ:CHRS) Consensus Price Target History

Coherus Biosciences (NASDAQ:CHRS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/29/2019MizuhoSet Price TargetBuy$43.00Medium
8/12/2019BarclaysSet Price TargetBuy$31.00Low
8/2/2019Maxim GroupReiterated RatingBuy ➝ Buy$25.00 ➝ $27.00High
8/2/2019HC WainwrightReiterated RatingBuy ➝ Buy$28.00 ➝ $29.00High
6/19/2019Robert W. BairdSet Price TargetBuy$28.00Low
3/7/2019Credit Suisse GroupSet Price TargetBuy$25.00Medium
11/2/2018CowenReiterated RatingBuy$45.00High
3/9/2018CitigroupBoost Price TargetBuy ➝ Buy$23.00 ➝ $25.00Low
(Data available from 10/21/2017 forward)
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel